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ABSTRACT The proteins of the pancreatic ribonuclease A (RNase A) family catalyze the cleavage of the RNA polymer chain.
The development of RNase inhibitors is of signiﬁcant interest, as some of these compounds may have a therapeutic effect
in pathological conditions associated with these proteins. The most potent low molecular weight inhibitor of RNase reported
to date is the compound 59-phospho-29-deoxyuridine-3-pyrophosphate (P/5)-adenosine-3-phosphate (pdUppA-39-p). The
39,59-pyrophosphate group of this compound increases its afﬁnity and introduces structural features which seem to be unique in
pyrophosphate-containing ligands bound to RNase A, such as the adoption of a syn conformation by the adenosine base at
RNase subsite B2 and the placement of the 59-b-phosphate of the adenylate (instead of the a-phosphate) at subsite P1 where
the phosphodiester bond cleavage occurs. In this work, we study by multi-ns molecular dynamics simulations the structural
properties of RNase A complexes with the ligand pdUppA-39-p and the related weaker inhibitor dUppA, which lacks the 39 and
59 terminal phosphate groups of pdUppA-39-p. The simulations show that the adenylate 59-b-phosphate binding position and the
adenosine syn orientation constitute robust structural features in both complexes, stabilized by persistent interactions with spe-
ciﬁc active-site residues of subsites P1 and B2. The simulation structures are used in conjunction with a continuum-electrostatics
(Poisson-Boltzmann) model, to evaluate the relative binding afﬁnity of the two complexes. The computed relative afﬁnity of
pdUppA-39-p varies between 7.9 kcal/mol and 2.8 kcal/mol for a range of protein/ligand dielectric constants (ep) 2–20, in
good agreement with the experimental value (3.6 kcal/mol); the agreement becomes exact with ep ¼ 8. The success of the
continuum-electrostatics model suggests that the differences in afﬁnity of the two ligands originate mainly from electrostatic
interactions. A residue decomposition of the electrostatic free energies shows that the terminal phosphate groups of pdUppA-
39-p make increased interactions with residues Lys7 and Lys66 of the more remote sites P2 and P0, and His
119 of site P1.
INTRODUCTION
The pancreatic ribonuclease A (RNase A) family contains
proteins, which decompose the RNA polymer chain (1,2).
Many members of the family display pathological side ef-
fects. For example, human angiogenin (3) is implicated in
cancer and in vascular and rheumatoid diseases (4); eosinophil-
derived neurotoxin and eosinophil cationic protein are
neurotoxic in vivo and are involved in hypereosinophilic
syndromes and allergy (5); and bovine seminal RNase has
antispermatogenic and immunosuppressive activity (6). The
activity of these proteins is critically affected by mutations of
residues involved in ribonucleolysis, or by ribonucleolytic
inhibitors (3,7,8). Thus, the development of RNase inhibitors
is of signiﬁcant interest, as some of these compounds may
act as therapeutic agents in pathological conditions associ-
ated with these proteins.
The RNase A catalytic site with a bound RNA molecule is
shown schematically in Fig. 1. According to the established
nomenclature (2), the active site is partitioned into subsites
fBig and fPig, which interact, respectively, with the RNA
bases and phosphate groups. Subsite B1 has a strong speci-
ﬁcity for pyrimidine bases, conferred by residue Thr45, which
is strictly conserved in all RNases. The protein cleaves the
P-O59 (scissile) bond on the 39 side of pyrimidine bases
bound at B1. Residues His
12, His119, and Lys41 (subsite P1) are
strictly conserved among RNase homologs and play key roles
in the reaction (2,9). Subsite B2 recognizes all bases, with a
preference for adenine. It is highly conserved, but other
subsites are more variable among homologs.
The high degree of B1, P1, and B2 homology suggests that
inhibitors of one protein may also act against other members
of the same family. Based on this expectation, structure-
assisted inhibitor design studies have mainly focused on
RNase A. Structural and kinetic studies have examined the
complexes between RNase A and several mono- or dinucle-
otide inhibitors containing adenine (10–17) or inosine (18) at
the 39 position of the scissile bond, and uracil (13–17) or
cytosine (11,12) at the 59 position. The high-resolution struc-
tures of several complexes have provided a detailed picture
of the inhibitor binding modes.
The most potent inhibitors (13–17) contain a nonstandard
pyrophosphate group, which increases the afﬁnity of nucle-
otide ligands by two orders of magnitude (14). Compounds
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ppA-39-p (Ki ¼ 240 nM) and ppA-29-p (Ki ¼ 520 nM) were
the ﬁrst inhibitors with this group (13,14). The compounds
bind to RNase A with the b-phosphate at site P1 and the
adenosine x angle in the syn range (13), structural features
that are unique to pyrophosphate-containing ligands (15–
17). Both inhibitors are strong, but do not make use of resi-
dues at subsites B1 and P0. To exploit potential interactions
with these sites, a 29-deoxy-59-phosphoyuridine group was
added to ppA-39-p to create the new ligand pdUppA-39-p.
The uridine moiety of pdUppA-39-p made numerous van der
Waals and hydrogen-bonding interactions with the RNase A
B1 and the 59-phosphate made medium-range Coulombic
interactions with the Lys66 NZ group at the P0 site; a hydro-
gen bond between the two groups could not be ruled out
from the crystal structure (15). Compound pdUppA-39-p is a
ninefold stronger inhibitor than ppA-39-p and the most po-
tent RNase inhibitor to date, with a Ki of 27 nm. It is also
effective against eosinophil-derived neurotoxin and RNase-4,
with respective Ki values of 180 nM and 260 nM.
In this work we investigate for the ﬁrst time by multi-
nanosecond simulations in explicit water the dynamical
behavior of RNase A complexes with two pyrophosphate
compounds: 1), the most potent inhibitor pdUppA-39-p; and
2), the related compound dUppA (16), which lacks the 39, 59
phosphate groups of pdUppA-39-p and has a Ki of 11.3 mM
for RNase A (16), corresponding to a weaker afﬁnity by 3.6
kcal/mol. The chemical structures of the two molecules are
shown in Fig. 2. The simulations reproduce essential features
of the crystallographic structures, and provide insights on the
ﬂexibility of the bound ligands and the surrounding active-
site residues.
The accurate computation of relative (19–26) or absolute
(27–33) binding afﬁnities has important applications in protein-
ligand docking and design, and has attracted considerable
computational effort in recent years. In this work, we eval-
uate the relative binding afﬁnity of the two RNase A com-
plexes by using the simulation conformations in conjunction
with a continuum-electrostatics (Poisson-Boltzmann) ap-
proximation (34–37). This continuum model yields results
in very good agreement with experiment, suggesting that
the electrostatic interactions contribute mostly to the stabil-
ity differences between the two complexes. We also evaluate
the contribution to binding due to speciﬁc protein-ligand
interactions and desolvation terms by a free-energy decom-
position analysis of the Poisson-Boltzmann free energies
(38,39).
In the next section, we describe the simulation methods
and the continuum model. The results are given in the fol-
lowing section. The ﬁnal section discusses the results and
summarizes the conclusions.
THEORY AND METHODS
Molecular dynamics simulations
The crystallographic structures of the pdUppA-39-p and dUppA complex
have been determined at a resolution of 1.7 A˚. The initial protein coordinates
were taken from these structures (accession codes 1QHC (15) and 1JN4 (16)).
The simulation system corresponded to a 29 A˚ sphere containing the entire
protein, the ligand, and 2997 water molecules. The sphere was centered on
the PB atom of the ligand. The water environment was created by retaining
135 crystallographic waters; additional water molecules were included by
overlaying a preequilibrated 32 A˚ water sphere on the complex and deleting
waters beyond 29 A˚ from the center of the complex, or overlapping with
protein-heavy atoms or crystallographic-water oxygen atoms. This overlay-
ing procedure was repeated 2–3 times during the equilibration of the two
complexes.
Atomic charges, van der Waals, and force-ﬁeld parameters corresponded
to the CHARMM22 all-atom force ﬁeld (40). The water was reproduced by a
modiﬁed TIP3P water model (41). Electrostatic interactions were calculated
by use of a multipole approximation (extended electrostatics) for groups
.14 A˚ apart (42); van der Waals interactions were switched to zero at dis-
tances.12 A˚. Water molecules were restrained to a spherical region of 29 A˚
radius by the stochastic boundary method (43). Water oxygen atoms in a
buffer beyond 23 A˚ from the center were subjected to random and frictional
forces mimicking a thermal bath at 293 Kelvin (44). Protein heavy atoms
beyond 16 A˚ from the center were harmonically restrained, based on the
crystallographic B-factors. Bond lengths with hydrogen atoms, and the ge-
ometry of water molecules were constrained by the SHAKE algorithm (45).
The classical equations of motion were integrated by a Verlet algorithmmod-
iﬁed for Langevin dynamics, using a time step of 1 fs.
To minimize structural perturbations in the molecular dynamics (MD)
simulations due to the omission of the bulk solvent beyond the simulation
FIGURE 1 Schematic representation of the RNase A active site, with a
bound RNA ligand. The subsites fBig and fPig, interacting, respectively,
with the RNA bases and phosphate groups are indicated. The ﬁgure is
adapted from Raines (2).
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sphere, the atomic charges of selected residues were scaled by a robust
inhomogeneous reaction-ﬁeld methodology, presented in Simonson et al.
(46) and tested in detail in the aspartyl-tRNA synthetase system in the lit-
erature (46–48). All residues treated by this scheme did not participate in salt
bridges and were located at least 20 A˚ away from the central phyrophosphate
group of either ligand, and at least 14.5 A˚ from the nearest terminal (59)
phosphate group of pdUppA-39-p. The scaled residues (scaling factors)
were Lys31(4.31), Lys61(4.15), Arg85(2.08), Lys91(4.63), Lys98(2.85), and
His105(2.39). The charges of side-chain atoms in these residues were divided
by the corresponding scaling factor. The resulting simulation system had a
total charge 0 for the dUppA complex.
In the crystallographic structures of the two complexes (15,16) there is no
electronic density associated with bound ions. Thus, the structural features
of the two complexes are not expected to depend on speciﬁc interactions
with solution ions, located at well-deﬁned positions. In the MD simulations,
the solution screening of electrostatic interactions was taken into account by
the scaling factors described above, without explicit counterions. In the
Poisson-Boltzmann (PB) calculations (below), the average ionic effect is
taken into account by setting the ionic concentration to the experimental
ionic strength of 0.2 M.
The simulations had a ﬁrst, 400-ps equilibration phase. In the subsequent
4-ns production phase, the protein and solvent coordinates were saved every
1 ps for analysis. All simulations were performed with the CHARMM
biomolecular program (49), Ver. c28b1.
Poisson-Boltzmann calculations
To calculate the continuum-electrostatics free energies of binding for the
various protein-ligand complexes, we evaluated the electrostatic potentials
for the protein alone, the ligand alone, and the protein-ligand complex by
solving the ﬁnite-difference Poisson equation on a three-dimensional grid.
For the three states (protein, ligand, complex) the same three-dimensional
grid and the same coordinates were used, so that the molecules were local-
ized in the same positions on the grid. This allowed artiﬁcial contributions to
the potential arising from the grid to be subtracted out exactly (50).
Finite-difference Poisson calculations were done for multiple (usually
200) structures taken from the 4 ns molecular dynamics trajectories of the
two complexes. Averaging over multiple structures was expected to improve
the precision and accuracy of the FDPB results (19,51). For each structure,
the Poisson-Boltzmann equation was solved ﬁrst on a large, coarse grid (0.8
A˚ spacing, 72–80 A˚ side), with screened Coulombic potentials on the grid
boundary, and then on a ﬁner grid (0.4 A˚ spacing, 56–64 A˚ side) with the
coarse solution as boundary conditions (focusing method (50)). The sizes of
FIGURE 2 Chemical structures of the compounds dUppA (a) and pdUppA-39-p (b). The atomic names and charges and the torsional angles discussed in the
text are indicated.
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the coarser grid were chosen so that a high-dielectric layer of minimal width
20 A˚ would surround the complex. The dielectric constant of the solvent was
set to 80. These of the protein and ligandwere taken to be equal; values of 1–20
were compared. Atomic radii and charges were taken from the CHARMM22
force ﬁeld used in the MD simulations, with the exception of the hydrogen
radii, which were set to 1.0 A˚. The protein-solvent boundary was deﬁned by
the molecular surface, constructed using a solvent probe radius of 2 A˚. The
ionic strength was set to the experimental value 0.2 M of monovalent coun-
terions. Additional calculations were performed at 0 M, to check the depen-
dence of the results on ionic concentration. All calculations were performed
with the UHBD program (52).
Electrostatic free energy component analysis
The derivation of the electrostatic components has been presented in Archontis
et al. (39) (see also (38)). We include it here, for the sake of convenience of
the reader.
The electrostatic free energy of a protein-ligand complex (PL) is given by
the expression (39,53)
G
PL ¼ 1
2
+
i2prot;lig
qiV
PL
i ¼
1
2
+
i2prot
qiV
PL
i 1
1
2
+
i2lig
qiV
PL
i ; (1)
where qi is the charge on atom i of the protein or ligand, and V
PL
i is the
electrostatic potential on atom i, in the solvated complex PL; analogous ex-
pressions yield the electrostatic free energies of the isolated protein (P) and
ligand (L).
The total electrostatic potential on atom i inside the complex PL can be
expressed as a sum over contributions from all ligand and protein atoms
V
PL
i ¼ +
j2lig
V
PL
j/i1 +
j2prot
V
PL
j/i; (2)
with VPLj/i the potential on atom i due to atom j in the complex PL. Using this
decomposition and the reciprocity relation qiV
PL
j/i ¼ qjVPLi/j (53), we arrive
at the following expression for the electrostatic free energy of the complex:
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(3)
The electrostatic binding free energy of the complex PL, DGbind, is equal to
the difference between the free energies of the complex and the isolated
protein and ligand in solution,
DGbind ¼ GPL  GP  GL: (4)
With the aid of Eq. 3, we obtain for DGbind (38,39):
DGbind ¼ +
i2prot;j2lig
qiV
PL
j/i1
1
2
+
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1
1
2
+
i2prot;j2prot
qi½VPLj/i  VPj/i
[DGPLint 1DG
L
desolv1DG
P
desolv: (5)
The ﬁrst term on the right-hand side of the Eq. 5 is a free-energy
component associated with the direct interaction between protein and ligand
charges in the solvated complex. The second term corresponds to the ligand
desolvation component, i.e., the change in the intraligand interactions upon
binding, due to changes in the ligand geometry or charge distribution, as
well as changes in the interaction of the ligand with polarization charge in
the surrounding medium. If the ligand is assumed to have the same geometry
and partial charges in the free and bound state (as here), this term arises
entirely from ligand interactions with the polarization charge. The last term
has an identical interpretation for the protein (38,39).
RESULTS
We ﬁrst discuss the dynamical behavior of the two com-
plexes and describe the important ligand-protein interactions
observed in the simulations. We then evaluate the relative
electrostatic binding free energy of the two complexes by a
Poisson-Boltzmann approximation, and identify the pro-
tein residues, which mostly contribute to the stabilization of
pdUppA-39-p with respect to dUppA by a free-energy com-
ponent analysis (38,39).
Simulation structures and interactions
Complex with dUppa
The Cartesian-coordinate root-mean-square (RMS) devia-
tion from the initial conformation is plotted in Fig. 3 as a
function of the simulation time. Note that t ¼ 0 corresponds
to the beginning of the production period, i.e., after 400 ps of
equilibration. The left and right panels show, respectively,
the dUppA and pdUppA-39-p complex results. The total
RMS deviation of the protein backbone heavy atoms (Fig. 3
A) is0.65 A˚ at the end of the 4-ns production period (4.4 ns
total time), showing that the protein conformation remains in
the close vicinity of the crystal structure.
The ligand conformations can be described by a set of
dihedral angles, deﬁned in Fig. 2. The glycosyl dihedral an-
gles x and x9 describe, respectively, the orientation of the
uracil and adenine rings, and the angles eU, h1, h2, z, and aA
characterize the conformation of the ligand pyrophosphate
group. The time evolution of these dihedral angles is shown
in Fig. 4 and the average values are listed in Table 1; for
dihedrals, which ﬂuctuate in more than one basin, we com-
pute separately and report the average value in each basin.
The time series of the glycosyl dihedral angles x and x9
for the dUppA ligand correspond to the solid curves in Fig. 4
A. The ﬂuctuations in the x9 angle are very small, signifying
that the x9 syn conformation is very stable throughout the
simulation; this conformation is observed in all RNase com-
plexes with the pyrophosphate-containing ligands dUppA
(16), pdUppA-39-p (15), and ppA-39-p (13). The x ﬂuctu-
ations are somewhat larger; however, the conformations of
both adenine and uracil rings stay close to the initial (x ray)
structure, with an RMS deviation of 0.7–0.8 A˚ at the end of
the 4-ns production period (Fig. 3 B) and an average RMS
positional ﬂuctuation of 0.6 A˚.
The pyrophosphate backbone is somewhat more ﬂexible;
the phosphate dihedrals h1, h2, z, and aA ﬂuctuate in the
vicinity of the x-ray values and around different rotamers
(Fig. 4 B and Table 1). The overall RMS positional ﬂuctu-
ation of the pyrophosphate atoms ranges between 0.45 A˚ and
0.85 A˚. Atom PB has the smallest RMS ﬂuctuation (0.45 A˚),
and a 0.6 A˚ RMS deviation from its initial position (Fig.
3 C). Thus, the PB position is very stable, in accord with the
observation that all pyrophosphate-containing ligands bind
with this phosphate at the P1 site (13,15–17). The RMS
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positional ﬂuctuation of atom a-phosphate (PA) is larger
(0.78 A˚) and its RMS deviation from the initial position is
;1.6 A˚ at the end of the simulation. The observed abrupt
changes in the PA RMS curve (Fig. 3 C) are due to tran-
sitions in the pyrophosphate dihedrals (Fig. 4 B). Thus,
the PA position seems to be less stable. However, the PA
atom forms interactions with important catalytic-site residues
throughout the simulations, as we show below.
We next discuss the ligand interactions with protein
residues and water molecules in the active site. The average
distances between atoms participating in protein-ligand hy-
drogen bonds, along with the average hydrogen-bond lengths
and occupancies are listed in Table 2. The time evolution of
selected distances between pyrophosphate and protein atoms
is plotted in Fig. 5.
In the crystal structures of RNase complexes with
pyrophosphate-containing ligands (13,15,16), the ligand
b-phosphate (PB) group interacts with the two catalytic
histidines His12 and His119, the proximal residues Gln11,
Phe120, and a water molecule. In our simulations this group
makes strong interactions with His12 and one or two water
molecules, and somewhat weaker interactions with His119,
Phe120, and Gln11. In the ﬁrst 2 ns, atom O1B interacts with
His119 and Phe120 (see Fig. 5). Atom O2B forms a strong
hydrogen bond with His12 and a weaker, direct or water-
mediated interaction with Q11. At 2 ns, the pyrophosphate
FIGURE 4 Time evolution of selected ligand dihe-
dral angles in the simulations of the two complexes.
The dihedral angles are deﬁned in Fig. 2 and Table 1.
(A) Dihedral angles x9 and x. The black and yellow
colors correspond, respectively, to the dUppA and
pdUppA-39-p ligand. (B) Ligand UppA pyrophosphate
dihedral angles h1, h2, z, and aA; (C) same as panel B,
for ligand pdUppA-39-p; and (D) terminal phosphate
dihedrals bU and eA of the ligand pdUppA-39-p.
FIGURE 3 Root-mean-square deviation of selected
groups of atoms from the starting conformation, plot-
ted as a function of the simulation time. The t¼ 0 value
corresponds to the end of the equilibration phase (400
ps). The results for complex dUppA are shown in plots
A–C; those for pdUppA-39-p are in plots D–F. Plots A
and D are protein main chain heavy atoms; plots B and
E are adenine and uracil ring atoms. Plots C and F are
phosphate PA and PB atoms. The net rotation and trans-
lation has been removed, by orienting all trajectory
frames with respect to the initial atomic coordinates of
the protein backbone heavy atoms.
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z dihedral angle undergoes a conformational transition (Fig.
4 B). Subsequently, O1B interacts with His12 and Phe120; the
Q11 interaction with both oxygens O1B and O2B is im-
proved. The O1B and O2B atoms are also hydrogen-bonded
to waters throughout the simulation (see Table 2). Atom O3
interacts with His119 in the last 1.5 ns.
The a-phosphate (PA) group interacts with residues Lys7
and His119. Atom O1A forms a strong hydrogen bond with
Lys7 in the ﬁrst 3 ns. Atoms O2A and O3A interact with
water molecules throughout the simulation and with His119
in the last 2 ns. For a brief period in the middle of the sim-
ulation, atom O2A makes an intramolecular hydrogen bond
with O5 (not shown). A simulation structure of the active site
region that is typical of the last 2-ns trajectory segment is
shown in Fig. 6.
The His119 side chain can adopt two conformations A and
B in the free RNase A, which differ by a rotation around the
x1 angle (54). In the crystallographic structure of the com-
plex, it is observed in conformation A (16). In the simula-
tions it is retained in this conformation, with a mean x1 value
of 152. The His119 and adenine rings form continuous p–p
stacking interactions, which presumably contribute to the
stabilization of the His119 A orientation and the adenine ring
syn orientation; the distance between the ring centers varies
between 3.0 and 5.0 A˚.
Residue Lys41 is located at a distance of 3.3 A˚ from atom
O3 in the crystal structure. In the simulation, it forms water-
mediated interactions with atoms O3 and the phosphate
groups of the ligand, and a (noncontinuous) direct hydrogen
bond for ;40% of the time with Gln11. The positional ﬂuc-
tuation of its terminal NZ atom is 1.5 A˚.
Thr45 confers to subsite B1 of RNases the speciﬁcity for
pyrimidine bases (2) by forming two hydrogen bonds with
the uridine atoms N3U and O2U. In the simulations, both
hydrogen bonds are almost continuously present (see Table
2). The uridine atom O4U forms indirect interactions with
the Ser123 and the Asp83 side chains, mediated by one or two
water molecules. Asp83 forms a second, continuous hydro-
gen bond with Thr45. The uridine ring forms displaced
stacking interactions with Phe120. The adenine base forms
two strong hydrogen bonds with Asn71 and weaker interac-
tions with Gln69. All these interactions are also observed in
the crystal structure of the complex (16).
The ligand makes extensive interactions with the solvent
(see Table 2). Each hydrogen-bonding atom of the ligand
interacts with several hundred different water molecules in
the course of the 4-ns simulation. The average (over all atoms)
lifetime of these bonds is2.3 ps; the largest average duration
(5.9 ps) corresponds to water interactions with atom O2B.
Residues Arg10 (site P2) and Lys
66 (P0) are located at dis-
tances .9 A˚ from the ligand phosphate groups and interact
with water. Lys66 forms a salt bridge with Asp121 for;0.5 ns.
Its side chain undergoes frequent conformational transitions
and the terminal NZ atom has a positional ﬂuctuation of
2.9 A˚. As we show below, this residue contributes to the
stronger afﬁnity of pdUppA-39-p for RNase A.
Complex with pdUppA-39-p
The time evolution of the Cartesian coordinates RMS devia-
tion is shown in the right panel of Fig. 3. The simulation
conformations remain close to the crystallographic structure.
The total RMS deviation of the protein backbone heavy
atoms (plot 3 D) and the ligand adenine and uracil rings (plot
3 E) converge to 0.6–0.7 A˚ at the end of the 4-ns produc-
tion period, in close similarity with the behavior of dUppA
complex. The glycosyl dihedral angles x and x9 are main-
tained near the x-ray values (plot 4 A, yellow curves), indi-
cating that the orientations of the two nucleotide rings are
very stable. The b-phosphate (PB) group of the pyrophos-
phate linker occupies a stable position at the P1 site, whereas
the a-phosphate group (PA) is more mobile; the average po-
sitional ﬂuctuations of the two phosphate atoms are, respec-
tively, 0.41 A˚ and 0.81 A˚. The pyrophosphate dihedrals h1,
h2, z, and aA undergo conformational transitions, as in the
dUppA complex (Fig. 4 C). The two terminal 59- and 39-
phosphate dihedrals bU and eA (see Fig. 2) ﬂuctuate mostly
in a single basin (plot 4 D).
The average distances of atoms participating in ligand-
protein hydrogen bonds, and the corresponding hydrogen-
bond statistics are included in Table 2. The time evolution of
selected distances is presented in Fig. 7. As in the dUppA
complex, the b-phosphate group forms two strong hydrogen
bonds with His12 and Phe120, and three somewhat weaker
TABLE 1 Average values of selected ligand dihedral angles,
observed in the simulations of the two complexes
Dihedral angle* dUppA X rayy pdUppA-39-p X rayz
Glycosyl dihedrals
O49U-C19U-N1U-C2U(x) 135/175§ 136 182/141 130
O49A-C19A-N9A-4A(x9) 64 76 65 85
Phosphate dihedrals
C4-C3-O3-PB(eU) 173/91 176 170 82
C3-O3-PB-O3A(h1) 80/133/180 121 69/142 106
O3-PB-O3A-PA(h2) 75/63/166 82 65/60 71
PB-O3A-PA-O59A(z) 86/179 100 102/152/138 95
O3A-PA-O59-C59(aA) 55/145/49 72 57/79 58
PA-O59-C59-C49(bA) 173 133 175 136
PG-O39-C39-C49(eA) 100 103
PD-O59-C59-C49(bU) 165 142
Backbone dihedrals
O59-C59-C49-C39(gU) 72/56 73 36/68 78
O59-C59-C49-C39(gA) 48/41 51 65/48 52
C59-C49-C39-O39(dU) 78/133 140 84/136 148
C59-C49-C39-O39(dA) 96 81 126 140
*The employed atom names and the corresponding dihedrals are shown in
Fig. 2.
yFrom Leonidas et al. (15).
zFrom Jardine et al. (16).
§For dihedrals which ﬂuctuate in more than one basin (see Fig. 4), we
compute separately and report the average value in each basin.
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bonds with His119, Gln11, and Lys7; the ﬁrst four interactions
are also present in the crystal structure (15). In the ﬁrst 2 ns,
atom O1B interacts with His119 and Phe120, whereas O2B
interacts with His12. Both oxygens form hydrogen bonds
with one or two water molecules, which sometimes bridge an
interaction with Gln11. The a-phosphate atoms O1A and
O2A interact, respectively, with Lys7 and His119; O3A
interacts with Q11. A typical MD structure of the ﬁrst 2-ns
portion of the simulation is shown in Fig. 8. At 2 ns, the
pyrophosphate z dihedral angle undergoes a conformational
transition; subsequently, O1B interacts with His12, Phe120,
and one or two waters, and O2B interacts with Lys7, water,
and Gln11. The interaction between the a-phosphate (atoms
O2A, O3A) and His119 is also improved.
Residue Lys41 forms a hydrogen bond with the ligand O3
atom in complex I of the crystallographic unit cell, with a
TABLE 2 Statistics of ligand-protein and ligand-water hydrogen bonds, observed in the simulations of the RNase A:dUppA and
RNase A:pdUppA-39-p complexes
dUppA pdUppA-39-p
Distance hb Distance hb
Atom pair* MDy X ray Lengthz Occupancy MDy X ray Lengthz Occupancy
O1B-F120 (N) 3.4 (0.4) 3.2 2.9 (0.0) 52 (%) 3.0 (0.4) 2.9 3.0 (0.2) 82 (%)
O1B-H12 (NE2) 3.6 (0.1) 3.2 (0.1) 51 3.3 (0.9) 3.1 (0.2) 63
O1B-H119 (ND1) 3.5 (0.8) 3.1 2.7 (0.0) 44 3.5 (0.7) 2.8 2.6 (0.1) 28
O1B-water 25
O2B-H12 (NE2) 3.5 (0.9) 2.8 2.7 (0.1) 49 3.4 (0.6) 2.4 2.7 (0.1) 37
O2B-K7 (NZ) 4.2 (1.7) 2.9 (0.2) 34
O2B-Q11 (NE2) 3.6 (0.6) 2.8 3.1 (0.1) 25 3.3 (0.5) 2.9 3.0 (0.2) 17
O2B-F120 (N) 4.6 (0.9) 3.2 (0.1) 8 4.8 (0.6) 3.2 (0.1) 2
O2B-water 138 100
394§ 365
O3-H119 (ND1) 3.9 (0.8) 3.0 (0.1) 29
O3-Q11 (NE2) 3.8 (0.6) 3.3 (0.0) 15
O3-water 40 62
70 88
O1A-K7 (NZ) 3.3 (0.9) 2.7 (0.1) 61 3.0 (0.7) 2.8 2.6 (0.0) 68
O1A-water 154 160
O2A-H119 (ND1) 4.2 (1.1) 3.0 3.0 (0.3) 28 3.3 (0.7) 3.4 3.2 (0.1) 58
O2A-water 198 148
O3A-H119 (ND1) 4.0 (0.8) 3.3 (0.1) 27 3.6 (0.8) 3.0 (0.2) 45
O3A-Q11 (NE2) 4.6 (0.8) 3.2 (0.1) 3 4.7 (0.8) 3.1 (0.2) 8
484 458
O2D-K66 (NZ) 5.7 (2.4) 2.8 (0.1) 17
17
O2G-K7 (NZ) 5.4 (2.1) 2.7 (0.1) 25
O3G-K7 (NZ) 2.7
25
N6A-N71 (OD1) 3.1 (0.4) 2.9 3.0 (0.3) 84 3.0 (0.2) 3.1 2.9 (0.2) 90
N6A-N67 (OD1) 3.6 (0.5) 3.0 (0.1) 21 3.8 (0.5) 3.3 3.2 (0.3) 17
106 109
N7A-N71 (ND2) 3.1 (0.2) 2.9 3.1 (0.1) 91 3.1 (0.2) 3.2 3.1 (0.2) 92
N7A-water 14 25
109 120
N1A-N67 (ND2) 3.3 (0.3) 3.1 3.0 (0.2) 26 3.3 (0.5) 3.4 3.2 (0.2) 33
N1A-water 37 44
63 77
N3U-T45 (OG1) 2.9 (0.1) 2.9 2.8 (0.1) 100 2.8 (0.1) 2.8 2.8 (0.1) 100
100 100
O2U-T45 (N) 3.0 (0.1) 2.8 3.0 (0.1) 83 3.0 (0.1) 2.8 3.0 (0.1) 89
83 89
O4U-water 107 101
All distances in A˚. The standard deviations are included in parentheses.
*The atomic names of the two ligands are indicated in Fig. 2.
yAverage distance (with standard deviations in parentheses) between the corresponding heavy atoms in the entire 4-ns trajectory.
zAverage distance (with standard deviations in parentheses) in the portion of the 4-ns trajectory, where a hydrogen bond is formed. The criteria for the
existence of a hydrogen bond employed here are 1), a maximum donor (D)-acceptor (A) distance of 3.4 A˚; and 2), a minimum : DHA of 120.
§Total hydrogen-bond occupancy for each ligand group.
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length of 3.1 A˚. In the simulations this hydrogen bond is
observed in the ﬁrst 500 ps (Fig. 7). Subsequently, Lys41
forms water-mediated interactions with the two pyrophos-
phate groups as in the dUppA complex; the positional ﬂuc-
tuation of its terminal NZ atom is 1.5 A˚.
Residue Lys7 forms two hydrogen bonds with the PA and
PG groups, with respective occupancies 70% and 25%
(Table 2). This behavior is in accord with the crystallo-
graphic structure, where Lys7 hydrogen-bonds to O1A in one
of the two complexes in the crystallographic unit cell and to
O3G in the second complex (15). The His119 ring is
maintained in conformation A with an average x1 angle of
153, and forms continuous p–p stacking interactions with
the adenine ring, as in the dUppA complex. Both residues
contribute to the higher relative afﬁnity of pdUppA-39-p (see
below).
The uridine and adenosine moieties of pdUppA-39-p inter-
act, respectively, with Thr45 and Asn71 via two strong hydrogen
FIGURE 6 Wall (left) and cross (right) stereo representations of a typical structure of the dUppA-complex active site, observed in the second 2-ns simulation
segment. The important interactions of dUppA with surrounding protein residues and waters are indicated.
FIGURE 5 Time evolution of selected dUppA-pro-
tein distances in the 4-ns production-phase simulation.
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bonds. The uridine ringmakes off-centered stacking interactions
with the Phe120 ring. The adenine moiety interacts also with
Asn67 and Gln69. Ser123 often makes water-mediated in-
teractions with O4U and Asp83. Arg10 is more remote (site
P2) and interacts mostly with water. All these interactions are
in close agreement with the crystal structure (15) and similar to
what was observed in the simulations of the dUppA complex.
The 59 (PD) terminal phosphate interacts with water mol-
ecules throughout the run. In 75% of the simulation length
it makes an intramolecular hydrogen bond with the oxygen
O2A of the a-phosphate (not shown). In the last ns it also
interacts on and off with Lys66 of subsite P0. This lysine
interacts also with solvent molecules throughout the simu-
lation. The positional ﬂuctuation of the Lys66 NZ atom is
3.2 A˚, slightly larger than in the dUppA complex (2.9 A˚). In
the crystal structure, the position of the same atom is well
deﬁned in molecule I and its distance from the nearest
oxygen of the PD phosphate is 4.7 A˚. In molecule II of the
FIGURE 7 Time evolution of selected pdUppA-39-
p-protein distances in the 4-ns production-phase sim-
ulation.
FIGURE 8 Wall (left) and cross (right) stereo representations of a typical structure of the pdUppA-39-p -complex active site, observed in the ﬁrst 2-ns
simulation segment. The important interactions of dUppA with surrounding protein residues and waters are indicated.
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unit cell there is no density beyond the Cb atom, suggesting
that Lys66 is ﬂexible. Even though Lys66 does not make strong
interactions with the ligand, its contribution in the higher
stability of the dUppA-39-p complex is signiﬁcant, as we
show in the next section.
As in the dUppA complex, the pdUppa-39-p ligand makes
numerous hydrogen-bonding interactions with the solvent
(see Table 2). Atom O2B hydrogen-bonds with 11 different
waters and forms the longest-living interactions (with aver-
age lifetime of 16.1 ps). Other ligand atoms interact typically
with several hundred different water molecules; when aver-
aged over all ligand atoms, the mean water-ligand hydrogen
bond lifetime is 3.1 ps.
Poisson-Boltzmann electrostatic association
free energies
Based on the experimental Ki values of the pdUppA-39-p and
dUppA ligands (27 nM and 11.3 mM), the pdUppA-39-p
complex is estimated to be more stable by 3.6 kcal/mol.
The net charge of the two ligands is 4 (pdUppA-39-p) and
2 (dUppA); that of RNase is18 at the experimental pH 5.5
of the solution (15,16). Thus, electrostatic interactions are
expected to be the most important factor affecting the sta-
bility of the two complexes.
The electrostatic association free energies of the two
complexes can be calculated by a Poisson-Boltzmann model
(34–37). Furthermore, a component analysis (38,39) can iden-
tify which protein or ligand groups contribute mostly to the
total free energy, and provide a better understanding of the
differences between the two complexes.
The total Poisson-Boltzmann binding free energies for the
two complexes are included in Table 3. To increase accuracy
(39,51,55), the results were averaged over 200 snapshots,
spanning the 4 ns simulations. The ionic strength of the
solution corresponded to the experimental value of 0.2 M
monovalent ion concentration. Additional calculations were
performed at 0 M, to investigate the dependence of the re-
sults on the ionic concentration.
The binding free energies of both complexes are negative,
implying that the electrostatic interactions promote associa-
tion. The pdUppA-39-p complex is more stable by 7.9 kcal/mol
(ep¼ 2) to 2.8 (ep¼ 20) kcal/mol at the experimental (0.2 M)
ionic strength. Thus, the PB results are in good agreement
with the experimental value of 3.6 kcal/mol for ep . 2;
notably, the experimental value is exactly reproduced with a
dielectric constant ep ¼ 8.
At 0 M, the association free energies are somewhat more
negative. This increase in the afﬁnity of oligonucleotide li-
gands for RNase A at low salt concentrations has been es-
tablished experimentally (56,57).
Poisson-Boltzmann free energy
component analysis
The relative electrostatic binding free energy obtained by PB
is in good agreement with experiment. To gain insight on the
interactions that increase the afﬁnity of pdUppA-39-p, we
separate the total electrostatic free energy of both com-
plexes into interaction and desolvation components. The
interpretation of these components was presented in Theory
and Methods. For a detailed discussion, see Archontis et al.
(39).
The results are included in Table 4. The interaction term
DGPLint is related to the direct electrostatic interaction energy
between protein and ligand charges in the solvated complex.
For both complexes it is negative, reﬂecting the fact that the
direct electrostatic interactions between protein and ligand
charges favor association. Its (absolute) value is larger in the
pdUppa-39-p complex (70.0 kcal/mol compared to 54.1
kcal/mol) due to the higher charge of this inhibitor.
The protein and ligand desolvation terms are related to the
change in the interaction of the protein (or ligand) with the
polarization charge of the surrounding medium, upon bind-
ing. Both terms are positive, reﬂecting the fact that the protein
and ligand interact more strongly with the induced charge in
their unbound state, where they are surrounded by the high-
dielectric solvent. The protein desolvation component is
somewhat more positive for the large inhibitor, in accord
TABLE 3 Total electrostatic binding energies for the two
complexes (kcal/mol)
dUppA pdUppA-39-p DDGbind
ep 0 M 0.2 M 0 M 0.2 M 0 M 0.2 M
2 17.5 (4.0) 14.1 (4.0) 28.1 (3.5) 22.0 (3.3) 10.6 7.9
4 14.3 (2.0) 11.0 (2.0) 22.1 (2.1) 16.1 (2.0) 7.8 5.1
8 12.3 (1.0) 9.1 (1.0) 18.7 (1.4) 12.8 (1.3) 6.4 3.7
16 10.9 (0.5) 7.8 (0.5) 16.6 (1.0) 10.7 (0.9) 5.7 2.9
20 10.4 (0.4) 7.4 (0.4) 16.0 (0.9) 10.2 (0.8) 5.6 2.8
Averages over 200 conformations spanning the 4 ns simulations. Values are
calculated with a water dielectric constant of 80 and a protein/ligand
constant of ep. The uncertainty (in parentheses) is computed as the standard
deviation of averages, which are obtained by partitioning the 4 ns trajectory
into four groups of 1 ns. The ionic strength of the experimental binding
measurements is 0.2 M.
TABLE 4 Decomposition of the total electrostatic
free-energies of Table 3 into interaction and desolvation
components (kcal/mol)
dUppA pdUppA-39-p DDG
DGPLinter 54.0 (2.1) 70.0 (3.7) 15.9
DGPdesolv 20.0 (0.6) 22.7 (0.8) 2.7
DGLdesolv 23.0 (0.6) 31.2 (1.1) 8.2
Total* 11.0 (4.5) 16.1 (5.4) 5.1
The various components were explained in Theory and Methods. Values
correspond to a protein/ligand dielectric constant of 4 and an ionic strength
of 0.2 M. The uncertainty (in parentheses) is computed as the standard
deviation of averages, which are obtained by partitioning the 4 ns trajectory
into four groups of 1 ns.
*The total values are taken from Table 3.
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with the larger reduction in the solvent-accessible surface
area of RNase A in the simulations of the pdUppA-39-p
complex (418 A˚2, compared to 372 A˚2 in the dUppA
complex, evaluated by the Lee-Richards algorithm with a
probe radius of 1.4 A˚). The ligand desolvation component is
signiﬁcantly more positive for pdUppA-39-p (31.2 kcal/mol,
compared to 23.0 kcal/mol). This can be attributed to the
additional two phosphate groups, which increase the total
interaction between pdUppA-39-p and the induced charge at
the ligand-solvent interface. The reduction in the solvent-
accessible surface area of pdUppA-39-p in the simulations is
664 A˚2, compared to 624 A˚2 for dUppA.
From the above analysis it follows that the increased rel-
ative stability of the pdUppA-39-p complex originates mainly
from enhanced electrostatic interactions between the pdUppA-
39-p ligand and the protein, reﬂected by the more negative
component DGPLint . Insight on the protein residues, which
mostly contribute to the increased afﬁnity of pdUppA-39-p,
can be obtained by further decomposing the term DGPLint into
residue contributions. The largest values are included in
Table 5. The meaning of these components is further ana-
lyzed in the next section and in Archontis et al. (39).
The most important contributions are due to residues Lys7,
His119, and Lys66. In Table 6 we decompose further these
residue terms into contributions from interactions with vari-
ous ligand moieties. Lys7 forms stronger interactions with
the pyrophosphate group and the 39-end moiety of pdUppa-
39-p, which contains the g-phosphate. This is in accord with
the hydrogen-bond analysis presented above. Residue Lys7
makes 1.27 hydrogen bonds (per frame) with the atoms O1A,
O2B, and O2G of pdUppA-39-p, compared to 0.61 hydrogen
bonds with atom O1A in dUppa. The next most important
residues His119 and Lys66 interact more strongly with the 59-
end (d-phosphate) and to a lesser extent with the intermediate
pyrophosphate group of pdUppa-39-p. His119 forms, respec-
tively, 1.31 and 1.28 hydrogen bonds (per frame) with
the pyrophosphate atoms O1B, O3, O2A, O2B of ligands
pdUppA-39-p and dUppA; the average H119(Nd1)–O3A
distance is somewhat smaller (3.0 A˚, compared to 3.3 A˚) in
the pdUppA-39-p complex, possibly contributing to a stronger
interaction.
DISCUSSION AND CONCLUSIONS
The Coulombic forces exerted by various RNase A subsites
on RNA analog substrates have been investigated by muta-
genesis experiments. According to these studies, Lys66 (site
P0) and the pair Lys
7/Arg10 (site P2) contribute, respectively,
0.9 kcal/mol and 1.2 kcal/mol to the binding of ﬂuorescein-
dAUAA (56) at a pH of 6.0; His12 and His119 (site P1)
contribute 1.4 kcal/mol and 1.1 kcal/mol to the binding of 39-
UMP at the same pH (58). These values are much smaller
than the corresponding residue free-energy components
DGPLint (Table 5). However, it should be noted that a PB
interaction free-energy component associated with residue R
(as the ones reported in Table 5) does not correspond quan-
titatively to the total free energy change of the complex due
to neutralization of R (even though it does provide a qual-
itative measure of the R contribution to the total binding
afﬁnity). Two other factors are likely to partly compensate
for this interaction free-energy component, yielding a smaller
total free-energy change. First, the neutralization of R changes
the polarization charge that is induced at the entire protein/
solvent interface (dissociated state) or complex/solvent in-
terface (bound complex state), modifying thereby the total
protein desolvation free-energy component. Furthermore,
the charge perturbation on R could cause structural relaxation
in the complex, which might perturb the interaction compo-
nents of other residues and change the total protein or ligand
desolvation components. A detailed discussion of the con-
nection between the PB free-energy components and mu-
tagenesis, and speciﬁc numerical examples for complexes
of the protein aspartyl-tRNA synthetase, are presented in
Archontis et al. (39).
TABLE 5 Contributions from selected residues to the
protein-ligand interaction component DGPLinter (kcal/mol)
Residue dUppA pdUppA-39-p DDGRinter
Lys7 9.3 (0.6) 17.9 (1.1) 8.6
His119 18.4 (0.3) 25.4 (0.6) 7.0
Lys66 0.8 (0.4) 4.3 (0.4) 3.5
His12 19.6 (0.1) 21.0 (0.0) 1.3
Lys41 5.2 (0.6) 5.5 (1.9) 0.2
Asp121 2.8 (0.1) 5.9 (0.3) 3.1
Total* 54.1 (2.1) 70.0 (3.7) 16.1
Values are calculated with a protein/ligand dielectric constant of 4 and ionic
strength of 0.2 M. The uncertainty (in parentheses) is computed as the
standard deviation of averages, which are obtained by partitioning the 4 ns
trajectory into 4 groups of 1 ns.
*Total value, listed in the ﬁrst row of Table 4.
TABLE 6 Decomposition of the residue-ligand relative
interaction free energies of Table 5 (term DDGRinter) into
contributions from ligand moieties (kcal/mol)
Ligand moiety Lys7 His119 Lys66 His12 Lys41
59-end* 0.5 4.1 2.7 0.9 0.7
Pyrophosphatey 5.3 1.7 0.7 0.1 0.8
39-endz 2.9 0.9 0.1 0.6 0.3
Total§ 8.6 7.0 3.5 1.4 0.3
All values are relative to the dUppA complex and correspond to a protein/
ligand dielectric constant of 4, a solvent dielectric constant of 80 and an
ionic strength of 0.2 M.
*The 59-end includes atoms H5T, O5, C5, HC51, HC52 (ligand dUppA)
and H5T, O3D, PD, O1D, O2D, O5, C5, HC51, HC52 (ligand pdUppA-39-p)
(see Fig. 2).
yThe pyrophosphate moiety includes atoms C3, HC3, O3, PB, O1B, O2B,
O3A, PA, O1A, O2A, O59, C59, HC591, HC592 for both ligands.
zThe 39-end moiety includes atoms C39, HC39, O39, H39 (ligand dUppA)
and C39, HC39, O39, PG, O1G, O2G, O3G, H3T (ligand pdUppA-39-p).
§Total value, listed in the last column of Table 5.
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In addition to the electrostatic free energies computed
here, the total absolute binding free energies contain contri-
butions from other factors, such as the nonpolar interactions,
the translational, conformational and vibrational entropy loss
of the ligand and protein, and the entropy gain due to the
release of water molecules (23,28–33,59–61).
An estimate of the nonpolar contribution to the relative
binding afﬁnity can be obtained by a standard surface model
(62). Given that the average reduction in the total solvent-
accessible surface area of the pdUppA-39-p and dUppA
complexes in the simulations is 1082 A˚2 and 996 A˚2, respec-
tively, the model yields an additional stabilization of the
pdUppA-39-p complex by 0.5 kcal/mol.
Contributions from ligand/protein entropic terms could
also be estimated by various approximate methods (23,28–
33,59–61). For example, the two additional dihedral angles
of pdUppA-3-9p, PD-O59-C59-C49(bU), and PG-O39-C39-
C49(eA), ﬂuctuate in a single minimum throughout the 4-ns
simulations (see Table 1 and Fig. 4 D). Assuming an average
loss of entropy per rotatable bond of 0.4–0.5 kcal/mol
(31,63), the restriction of these angles upon association desta-
bilizes the pdUppA-3-9p complex by 0.8–1.0 kcal/mol,
with respect to dUppA. Additional contributions due to the
ligand translational/rotational and the protein side-chain en-
tropy are likely to cancel approximately in the relative free
energy difference, because the two ligands are similar, bind
at the same position/orientation in the complex and have
similar positional ﬂuctuations in the simulations. We thus do
not compute them here.
Other factors that could introduce inaccuracies in the
continuum model are the use of charges/radii optimized for
molecular mechanics calculations and the use of uniform
dielectric constants for the protein/ligand and solvent, despite
the contrary evidence from simulations (37,64–68). Further-
more, the protein and ligand structures are assumed identical
in the complex and the dissociated states in our calculations.
The structural ﬂuctuations of the complex are taken into
account by averaging the results over the 4-ns trajectories,
but any protein/ligand relaxation upon dissociation is only
implicitly taken into account via the dielectric constant
(36,55,69–71). Given these approximations and the appre-
ciable ligand sizes (68 and 73 atoms), it is noteworthy that
our continuum model yields relative binding free energies in
excellent agreement with experiment for ep ¼ 8, and fair
agreement in the entire range ep ¼ 2–20.
Ligand-design methods based on PB calculations of single
(e.g., energy-minimized) conformations may be successful
in ranking a family of complexes, provided their docking/
energy minimization protocols produce representative con-
formations. An example of such a high-throughput docking/
continuum electrostatics method, which discovered a set of
b-secretase inhibitors, is presented in Huang et al. (25). In
the case of the two RNase A complexes considered here, the
x-ray conformations are indeed sufﬁcient for the accurate
evaluation of the relative binding afﬁnity; PB calculations
with the x-ray structures yield a result of 5.3 kcal/mol in
favor of the pdUppa-39-p ligand (with a protein/ligand di-
electric constant ep ¼ 4 and an ionic strength of 0.2 M), in
perfect agreement with the corresponding simulation average
(5.1 kcal/mol; see Table 3). On the other hand, MD sim-
ulations are likely to provide more representative structures
in some systems, e.g., when a ligand or protein mutation is
associated with structural relaxation (26,39). The computa-
tional requirements of such MD-based ligand design methods
may be reduced by using a more approximate free-energy
scoring function, such as in the linear interaction energy
approach (20,26).
In conclusion, in this work we have studied by molecular
dynamics simulations and Poisson-Boltzmann calculations
the complexes between RNase A and the two dinucleotide
inhibitors dUppA and pdUppa-39-p. The simulations repro-
duce structural features which are characteristic of complexes
between RNases and pyrophosphate-containing nucleotidic
inhibitors (13–17); in particular, the b-phosphate group of each
ligand interacts with the P1 site residues His
12 and His119,
Gln11, and Phe120 (Table 2), in agreement with the crystal
structures (15,16). The b-phosphate position is very stable,
with an RMS deviation from the crystal structure of 0.6 A˚ at
the end of the 4.4 ns simulation (Fig. 3) and an overall
positional (RMS) ﬂuctuation of 0.41–0.45 A˚. The interaction
with His12, which is persistent throughout the simulations,
presumably contributes to the stability. The a-phosphates are
more mobile, with a positional ﬂuctuation of 0.78–0.81 A˚,
and interact mainly with Lys7 and His119. The syn orientation
of the adenosine ring, which characterizes RNase com-
plexes with pyrophosphate-containing ligands, is maintained
throughout the simulations; it is stabilized in part by stack-
ing interactions with His119. The direct and water-mediated
hydrogen-bonding interactions of the two bases with the
RNase catalytic-site residues are well reproduced.
Continuum electrostatics calculations predict that the
pdUppa-39-p ligand binds to RNase A with a relative afﬁnity
that ranges between 7.9 kcal/mol (protein/ligand dielectric
ep ¼ 2) and 2.8 kcal/mol (ep ¼ 20). The experimental
relative value, 3.7 kcal/mol, is reproduced with an ep ¼ 8.
The good agreement of the continuummodel with the experi-
mental relative afﬁnities suggests that the electrostatic inter-
actions are mainly responsible for the different stability of
the two complexes.
The present computational study provides further insight
into the remarkable differences in potency of the two inhib-
itors, which complements efﬁciently the previous crystallo-
graphic results (15,16). A free-energy decomposition shows
that the increased afﬁnity of RNase for the pdUppa-39-p
ligand is mainly due to interactions with Lys7, His119, and
Lys66 (Table 5). The interactions of Lys7 and Lys66, respec-
tively, with the 39 and 59 phosphate groups and the sta-
bilizing role of these two groups in the overall conformation
of pdUppA-39-p, both inferred from the present study and
from the crystal structures (15,16), seem to be the main
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reason for the differences in the potency of the two in-
hibitors.
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